Replies to post #4312 on VeriTeQ Corp. (fka VTEQ)

[Kurupt]

We note that the press release from February 12th, 2015 is a very interesting development for VeriTeQ Corp.

Essentially, the term sheet the company has executed gives Establishment Labs, S.A. “EL” the option to exclusively license VeriTeQ’s intellectual property, safety data test and FDA file reference, and business opportunities related to its Q Inside Safety Technology for the breast implant market for an upfront license fee of $1.75 million with a 24-month option to purchase VeriTeQ’s Q Inside Safety Technology business for the breast implant market for $10 million, minus the license fee.

[Kurupt]

Dont count them out yet. Iam wishing the next PR or 2 announcing a Joint Venture agreement!!


Perhaps even more interesting, is the fact that we have yet to hear about Mentor or Allergen on this matter. These companies together represent 81% of the breast implant market, and currently have no competing technologies in development. Knowing the FDA’s new requirements, as well as the cost
associated with developing a technology like VeriTeQ’s, it would seem logical that VeriTeQ could begin to receive interest from these major players in the implantation market.